Peroxisome Proliferator-Activated Receptors
"Peroxisome Proliferator-Activated Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
TRANSCRIPTION FACTORS that are activated by ligands and heterodimerize with RETINOID X RECEPTORS and bind to peroxisome proliferator response elements in the promoter regions of target genes.
Descriptor ID |
D047492
|
MeSH Number(s) |
D12.776.260.698.239 D12.776.826.239 D12.776.930.669.239
|
Concept/Terms |
Peroxisome Proliferator-Activated Receptors- Peroxisome Proliferator-Activated Receptors
- Peroxisome Proliferator Activated Receptors
- Proliferator-Activated Receptors, Peroxisome
- Receptors, Peroxisome Proliferator-Activated
- PPAR
|
Below are MeSH descriptors whose meaning is more general than "Peroxisome Proliferator-Activated Receptors".
Below are MeSH descriptors whose meaning is more specific than "Peroxisome Proliferator-Activated Receptors".
This graph shows the total number of publications written about "Peroxisome Proliferator-Activated Receptors" by people in this website by year, and whether "Peroxisome Proliferator-Activated Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 | 2006 | 1 | 0 | 1 | 2012 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Peroxisome Proliferator-Activated Receptors" by people in Profiles.
-
Li S, Nagothu K, Ranganathan G, Ali SM, Shank B, Gokden N, Ayyadevara S, Megyesi J, Olivecrona G, Chugh SS, Kersten S, Portilla D. Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury. Am J Physiol Renal Physiol. 2012 Aug 01; 303(3):F437-48.
-
Liebson PR. Muraglitazar and the FDA: what constitutes drug safety? Prev Cardiol. 2006; 9(2):110-4.
-
Avis I, MartÃnez A, Tauler J, Zudaire E, Mayburd A, Abu-Ghazaleh R, Ondrey F, Mulshine JL. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition. Cancer Res. 2005 May 15; 65(10):4181-90.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|